Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
|
Bioorg Med Chem Lett
|
2005
|
1.92
|
2
|
Synthesis of new chalcone derivatives bearing 2,4-thiazolidinedione and benzoic acid moieties as potential anti-bacterial agents.
|
Eur J Med Chem
|
2011
|
1.15
|
3
|
Synthesis and anti-tumor evaluation of panaxadiol derivatives.
|
Eur J Med Chem
|
2011
|
0.94
|
4
|
Synthesis of new chalcone derivatives containing a rhodanine-3-acetic acid moiety with potential anti-bacterial activity.
|
Eur J Med Chem
|
2010
|
0.92
|
5
|
Novel dammarane-type sapogenins from Panax ginseng berry and their biological activities.
|
Bioorg Med Chem Lett
|
2010
|
0.89
|
6
|
Anticonvulsant and toxicity evaluation of some 7-alkoxy-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline-1(2H)-ones.
|
Bioorg Med Chem
|
2006
|
0.89
|
7
|
Synthesis and anti-bacterial activity of some heterocyclic chalcone derivatives bearing thiofuran, furan, and quinoline moieties.
|
Arch Pharm (Weinheim)
|
2011
|
0.86
|
8
|
Synthesis of novel 1,3-diaryl pyrazole derivatives bearing rhodanine-3-fatty acid moieties as potential antibacterial agents.
|
Eur J Med Chem
|
2011
|
0.83
|
9
|
Characterization of the anticonvulsant activity of doxepin in various experimental seizure models in mice.
|
Pharmacol Rep
|
2009
|
0.82
|
10
|
Synthesis and bioactivity evaluation of rhodanine derivatives as potential anti-bacterial agents.
|
Eur J Med Chem
|
2012
|
0.82
|
11
|
Synthesis and anticonvulsant activity of 7-alkoxyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolines.
|
Bioorg Med Chem Lett
|
2005
|
0.81
|
12
|
Synthesis and antitumor activity of dehydroepiandrosterone derivatives on Es-2, A549, and HepG2 cells in vitro.
|
Chem Biol Drug Des
|
2012
|
0.79
|
13
|
Synthesis and antimicrobial evaluation of L-phenylalanine-derived C5-substituted rhodanine and chalcone derivatives containing thiobarbituric acid or 2-thioxo-4-thiazolidinone.
|
Eur J Med Chem
|
2012
|
0.79
|
14
|
Synthesis and antibacterial evaluation of rhodanine-based 5-aryloxy pyrazoles against selected methicillin resistant and quinolone-resistant Staphylococcus aureus (MRSA and QRSA).
|
Eur J Med Chem
|
2012
|
0.78
|
15
|
Synthesis and biological evaluation of rhodanine derivatives bearing a quinoline moiety as potent antimicrobial agents.
|
Bioorg Med Chem Lett
|
2013
|
0.78
|
16
|
Synthesis and biological evaluation of (±)-3-(2-(2-fluorobenzyloxy) naphthalen-6-yl)-2-aminopropanoic acid derivatives as novel PTP1B inhibitors.
|
Eur J Med Chem
|
2011
|
0.78
|
17
|
Synthesis and biological evaluation of 5-aryloxypyrazole derivatives bearing a rhodanine-3-aromatic acid as potential antimicrobial agents.
|
Bioorg Med Chem Lett
|
2012
|
0.78
|
18
|
Synthesis and anticonvulsant activity of 1-substituted-7-benzyloxy-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline.
|
Biol Pharm Bull
|
2005
|
0.78
|
19
|
25-Methoxylprotopanaxadiol derivatives and their anti-proliferative activities.
|
Steroids
|
2013
|
0.77
|
20
|
Synthesis and anticonvulsant activity of N-(2-hydroxyethyl) cinnamamide derivatives.
|
Eur J Med Chem
|
2009
|
0.76
|
21
|
Synthesis and biological evaluation of 2,4,6-trihydroxychalcone derivatives as novel protein tyrosine phosphatase 1B inhibitors.
|
Chem Biol Drug Des
|
2012
|
0.75
|
22
|
Synthesis and characterization of 5,7-dihydroxyflavanone derivatives as novel protein tyrosine phosphatase 1B inhibitors.
|
J Enzyme Inhib Med Chem
|
2012
|
0.75
|
23
|
Evaluation of anticonvulsant activity of QUAN-0806 in various murine experimental seizure models.
|
Pharmazie
|
2009
|
0.75
|
24
|
Synthesis and biological evaluation of (E)-1-(substituted)-3-phenylprop-2-en-1-ones bearing rhodanines as potent anti-microbial agents.
|
J Enzyme Inhib Med Chem
|
2013
|
0.75
|
25
|
Design, synthesis of 8-alkoxy-5,6-dihydro-[1,2,4]triazino[4,3-a]quinolin-1-ones with anticonvulsant activity.
|
Eur J Med Chem
|
2008
|
0.75
|
26
|
Novel arylhydrazone derivatives bearing a rhodanine moiety: synthesis and evaluation of their antibacterial activities.
|
Arch Pharm Res
|
2013
|
0.75
|
27
|
Synthesis and anticonvulsant activity of N-(2-hydroxy-ethyl)amide derivatives.
|
Arch Pharm (Weinheim)
|
2009
|
0.75
|
28
|
Synthesis and positive inotropic evaluation of N-(1-oxo-1,2,4,5-tetrahydro-[1,2,4]triazolo[4,3-a]quinolin-7-yl)acetamides bearing piperazine and 1,4-diazepane moieties.
|
Bioorg Med Chem Lett
|
2012
|
0.75
|
29
|
Synthesis and positive inotropic evaluation of (E)-2-(4-cinnamylpiperazin-1-yl)-N-(1-substituted-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolin-7-yl)acetamides.
|
Arch Pharm (Weinheim)
|
2012
|
0.75
|
30
|
Synthesis of novel 7-benzylamino-2H-1,4-benzoxazin-3(4H)-ones as anticonvulsant agents.
|
Eur J Med Chem
|
2007
|
0.75
|
31
|
Synthesis of 2-(4-substitutedmethylpiperazin-1-yl)-N-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]oxazin-7-yl)acetamides and their positive inotropic evaluation.
|
Eur J Med Chem
|
2008
|
0.75
|
32
|
Synthesis and antibacterial activity of novel 1,3-diphenyl-1H-pyrazoles functionalized with phenylalanine-derived rhodanines.
|
Eur J Med Chem
|
2012
|
0.75
|
33
|
Synthesis and biological evaluation of [1,2,4]triazolo[3,4-a]phthalazine and tetrazolo[5,1-a]phthalazine derivatives bearing substituted benzylpiperazine moieties as positive inotropic agents.
|
Chem Biol Drug Des
|
2013
|
0.75
|
34
|
Synthesis and positive inotropic evaluation of 2-(4-(4-substituted benzyloxy)-3-methoxybenzyl)-1,4-diazepan-1-yl)-N-(4,5-dihydro-1-methyl[1,2,4]triazolo[4,3-a]quinolin-7-yl)-acetamides.
|
Arch Pharm (Weinheim)
|
2008
|
0.75
|
35
|
Synthesis and anti-inflammatory activity evaluation of novel 7-alkoxy-1-amino-4,5-dihydro[1,2,4]triazole[4,3-a]quinolines.
|
Arch Pharm (Weinheim)
|
2008
|
0.75
|
36
|
[Preparation and isolation on the rare ginsenoside derivatives with anti-cancer activity].
|
Zhong Yao Cai
|
2009
|
0.75
|
37
|
Synthesis and inotropic evaluation of 1-substituted-N-(4,5-dihydro-1-methyl-[1,2,4]triazolo[4,3-a]quinolin-7-yl)piperidine-4-carboxamides.
|
Bioorg Med Chem Lett
|
2009
|
0.75
|
38
|
Synthesis and anti-tumor evaluation of novel 25-hydroxyprotopanaxadiol analogs incorporating natural amino acids.
|
Steroids
|
2012
|
0.75
|
39
|
Synthesis of 2-(4-substitutedbenzyl-[1,4]diazepan-1-yl)-n-(1-methyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolin-7-yl)acetamides as inotropic agents.
|
Chem Biol Drug Des
|
2010
|
0.75
|
40
|
Synthesis of 2-(4-substituted benzyl-1,4-diazepan-1-yl)-N-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]oxazin-7-yl)acetamides and their positive inotropic evaluation.
|
Bioorg Med Chem Lett
|
2010
|
0.75
|
41
|
Synthesis and positive inotropic activity of N-(4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolin-7-yl)-2-(piperazin-1-yl)acetamide derivatives.
|
Bioorg Med Chem Lett
|
2008
|
0.75
|
42
|
Semi-synthesis and anti-tumor evaluation of novel 25-hydroxyprotopanaxadiol derivatives.
|
Eur J Med Chem
|
2012
|
0.75
|
43
|
Synthesis of new triazole acetamides with inotropic effects.
|
Bioorg Med Chem Lett
|
2012
|
0.75
|
44
|
Synthesis and in-vitro inotropic evaluation of 2-(4-substitutedbenzyl-1,4-diazepan-1-yl)-N-(4,5-dihydro-1-phenyl-[1,2,4]triazolo[4,3-a]quinolin-7-yl)acetamides.
|
Arch Pharm (Weinheim)
|
2010
|
0.75
|